Doxorubicin plus metronidazole in the treatment of recurrent or metastatis squamous cell carcinoma of the head and neckSTEWART, D. J; CRIPPS, M. C; LAMOTHE, A et al.American journal of clinical oncology. 1993, Vol 16, Num 2, pp 113-116, issn 0277-3732Article

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancerROTHENBERG, M. L; MOORE, M. J; STORNIOLO, A.-M et al.Annals of oncology. 1996, Vol 7, Num 4, pp 347-354, issn 0923-7534, 7 p.Article

Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphomaMEYER, R. M; QUIRT, I. C; ZEE, B et al.The New England journal of medicine. 1993, Vol 329, Num 24, pp 1770-1776, issn 0028-4793Article

Effects of PALA on the pharmacokinetics of 5-fluorouracilNASSIM, M. A; ROUINI, M. R; STEWART, D. J et al.Oncology reports. 1998, Vol 5, Num 1, pp 217-221, issn 1021-335XArticle

Improvements in survival and Clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer : A randomized trialBURRIS, H. A; MOORE, M. J; NELSON, R et al.Journal of clinical oncology. 1997, Vol 15, Num 6, pp 2403-2413, issn 0732-183XArticle

Cancer physicians' attitudes toward colorectal cancer follow-upEARLE, C. C; GRUNFELD, E; COYLE, D et al.Annals of oncology. 2003, Vol 14, Num 3, pp 400-405, issn 0923-7534, 6 p.Article

Multiple resistance modulators combined with carboplatin for resistant malignancies : A pilot studySTEWART, D. J; GOEL, R; CRIPPS, M. C et al.Investigational new drugs. 1997, Vol 15, Num 4, pp 267-277, issn 0167-6997Article

Pilot study of multiple chemotherapy resistance modulators plus epirubicin in the treatment of resistant malignanciesSTEWART, D. J; CRIPPS, M. C; GOEL, R et al.Cancer chemotherapy and pharmacology. 1997, Vol 41, Num 1, pp 1-8, issn 0344-5704Article

Duration of intravenous antibiotics for patients with neutropenic feverTOMIAK, A. T; YAU, J. C; STEWART, D. J et al.Annals of oncology. 1994, Vol 5, Num 5, pp 441-445, issn 0923-7534Article